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Pregnancy has measurable effects on essen­
tially every organ system in a woman’s 
body. An understanding o f these changes is 
vital for determining what is normal or ab­
normal in a pregnant woman. These 
changes frequently alter symptoms and 
signs of surgical diseases during pregnancy. 
In addition, many surgical diseases, as well 
as their therapies, have multisystemic ef­
fects. It therefore is mandatory to appre­
ciate the physiologic changes that occur in 
a normal pregnancy to avoid incorrect di­
agnoses and treatments.
The mechanisms behind these physio­
logic changes are complex and not always 
well understood. However, many are me­
diated via progressive increases in preg­
nancy-associated hormones, such as pro­
gesterone, estrogens, and human placental 
lactogen, or by progressive increases in ma­
ternal cardiac output and blood volume.
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This article will review these physiologic 
changes, concentrating on an organ-system 
format, with particular emphasis on man­
ifestations that might be confused with sur­
gical diseases or that have implications for 
treatment.
Optimum Weight Gain
Optimum weight gain during pregnancy is 
dependent upon the patient’s preconceptual 
nutritional status. In thin women, optimum 
pregnancy outcome occurs with weight 
gains o f25-35 pounds. The enlarging uterus 
and its contents contribute to the woman’s 
weight 11-14 pounds at term, but the ma­
jority of the remaining weight gain is caused 
by progressive expansion of maternal blood 
volume (3-4 pounds) and involuntary ca­
loric retention in the forms of fat and pro­
tein (4-6 pounds). The latter occur princi­
pally in the second trimester. Maternal ca­
loric retention is caused by the body’s 
anticipation o f the progressive late preg­
nancy caloric requirements o f the fetus as
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TABLE 1. Recommended Daily Allowances for Pregnancy and Lactation
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Nutrient
Additional Requirements for Additional Requirements for 
For Nonpregnant Women Pregnant Women Lactating Women
Calories (kcal) 
Protein (gm) 
Vitamin A (RE) 
Vitamin D (pg) 
Vitamin E (mg) Ascorbic acid (rag) 




Vitamin B6 (mg) Vitamin B12 (pg) 
Calcium (mg) Phosphorus (rag) 
Iodine 0/g)














































well as the increased caloric requirements 
o f lactation. Other contributions to mater­
nal weight gain include extracellular fluid 
(2-3 pounds) and breast enlargement (1-2 
pounds). Obese women have optimum 
pregnancy outcomes with weight gains of 
15-20 pounds and characteristically have 
less weight gain in the second trimester than 
do thin women. Obese women already have 
a substantially expanded vascular volume 
as well as an adequate caloric reserve.
In surgical patients, nutrition may be 
compromised by prolonged periods without 
oral intake. Although 5%-dextrose solution 
supplies minimal energy substrate, it is 
usually sufficient to maintain the patient 
and fetus for several days.1 However, those 
patients who require longer periods of par­
enteral nutrition without enteral nutrition 
may require nutritional supplementation 
with total parenteral nutrition (TPN). The 
indications for starting TPN in a pregnant 
patient include situations in which the 
bowel is not functional, such as biliary dis­
ease, pancreatitis, or complex bowel sur­
gery, and diseases requiring prolonged 
bowel rest. If  prolonged bowel rest is antic­
ipated, TPN should be started before the
patient's own nutritional stores are de­
pleted. Whenever the bowel is functional, 
but the patient is unable to eat, for example 
with hyperemesis gravidarum or oral sur­
gery, enteral nutrition via feeding tube is 
appropriate.
Firm guidelines for the pregnant patient 
do not exist for TPN or enteral nutrition. 
Therefore, a team approach between the 
obstetrician and nutritionist is desirable. 
This should include routine laboratory 
studies as well as periodic ultrasonography 
to verify fetal growth. Persistent ketonuria 
should be avoided, and indicates insuffi­
cient nutritional supplementation. Most 
importantly, malnutrition is best avoided 
rather than corrected, especially in the 
pregnant woman.
Over the years, a substantial effort has 
gone into the definition o f recommended 
dietary allowances during pregnancy and 
lactation. These recommendations are 
listed in Table l.2
Female Reproductive Tract
The increase in uterine size during preg­
nancy is due primarily to cellular hypertro­
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phy but is also the result o f modest hyper­
plasia. There is a 20-fold increase in cellular 
mass and a thousandfold increase in intra­
uterine volume.
Uterine blood flow also increases enor­
mously. Uterine artery blood flow increases 
from approximately 50 ml/min in the non­
pregnant woman to 600 ml/min at the end 
o f pregnancy. These increases are primarily 
estrogen-mediated and are critical for ad­
equate delivery o f oxygen and nutrients to 
the developing fetus. Uterine blood flow 
also may be affected by many drugs and 
maternal conditions (Table 2).
There is also a 60-fold increase in pelvic 
venous capacity by the end o f pregnancy. 
These dilated pelvic veins are a frequent 
site o f thromboembolisms. Although preg­
nancy is associated with a modest increased 
incidence in thromboembolic disease, there 
is a substantial additional increase in such 
complications in the first few weeks post­
partum. Women with reproductive tract 
infections and/or operative deliveries are at 
a particularly increased risk. Pregnant 
women requiring surgery are also at an in­
creased risk over the general population for 
thromboembolic disease. This necessitates 
appropriate prophylactic measures during 
surgery, usually with pneumatic compres­
sion devices.
Increases in blood volume within the 
uterus and pelvic vasculature represent ap­
proximately 1,000 ml at any moment late 
in pregnancy. This increased volume is not 
the result o f shunting from elsewhere in the 
maternal circulation but rather represents 
an increase o f maternal blood volume and 
cardiac output during pregnancy.
The breasts increase in size from early 
in pregnancy in anticipation of lactation. 
The enlargement of the ductal system is due 
primarily to estrogen, and the enlargement 
of the alveolar system is due to progester­
one. A complex interaction o f estrogen, 
progesterone, prolactin, human placental 
lactogen, insulin, and cortisol is required 
for lactation.
TABLE 2. Drugs and/or Maternal Conditions 
That May Affect Uterine 
Blood Flow
Increased uterine blood flow Correction o f acute factors (vide infra) responsible 
for decreased uterine blood flow 
Estrogens (specifically estradiol)
Prostaglandins (especially PGI2, PGE2)










Vacoconstrictors Alpha-adrenergic drugs 
Excess sympathetic discharge
PGIj = prostacyclin; PGEj = prostaglandin E2.
Cardiovascular System
Cardiac output increases by 30-50% during 
pregnancy, from a level of 4.0-4.51/min in 
nonpregnant women to a maximum during 
pregnancy of approximately 6 .01/min.3 The 
increase in output is directed primarily to 
the maternal uterus, kidneys, and skin, and 
does not represent shunting from other or­
gans. Cardiac output is the product of heart 
rate and stroke volume, which both increase 
during normal pregnancy. Stroke volume 
increases early in pregnancy, then decreases 
somewhat near term, and the maternal 
pulse gradually increases through the course 
o f pregnancy to 15-20 beats/min over rates 
in nonpregnant women.
As previously stated, maternal blood 
volume also is increased by 30-50% during 
pregnancy. However, maternal red blood 
cell volume is only increased by 20-30%. 
This results in a decrease in hematocrit 
throughout the course o f pregnancy, even 
though total maternal oxygen-carrying ca­
pacity is increased. In fact, failure o f the 
maternal hematocrit to decrease during 
pregnancy (i.e., the failure o f the maternal 
blood volume to expand) is associated with
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a distinct increased risk o f suboptimum 
pregnancy outcome. This mechanism is 
probably in a large part under genetic con­
trol.4 Certainly, it is not necessary to impose 
large quantities o f iron and vitamin sup­
plements on pregnant women to overcome 
this physiologic hemodilution; however, the 
maternal hematocrit should be maintained 
above 30% to facilitate optimum oxygen 
supply to the fetus. This may require a lower 
threshold for transfusion in the pregnant 
woman after acute surgical blood loss.
Circulatory volume expansion may in­
terfere with the diagnosis of surgical disease 
during pregnancy. This is seen mainly in 
situations o f hypovolemia, because tachy­
cardia and hypotension may not develop in 
pregnant patients until they lose 30-35% of 
their expanded circulating blood volume.1 
This maternal blood volume expansion is 
also partly responsible for the altered med­
ication requirements frequently seen during 
pregnancy.
There is a progressive increase in lower 
extremity venous pressure during preg­
nancy. This is the result o f several factors, 
including the expanded blood volume and 
compressive effects of the enlarged uterus. 
The ovarian artery and venous plexus com­
press the right common iliac vein. This lat­
ter effect explains why many of the signs 
and symptoms o f increased lower extremity 
venous pressure, such as varicosities, are 
more frequent and more severe on the ma­
ternal right side. Upper extremity venous 
pressure and central venous pressure re­
main unchanged during pregnancy.
There is a decrease in systemic vascular 
resistance during pregnancy. When com­
bined with the increase in cardiac output 
and blood volume, several characteristic 
changes can be expected on physical ex­
amination. Because the uteroplacental bed 
functions as a  low-pressure, left-to-right 
shunt, the maternal blood pressure char­
acteristically drops during the midportion 
o f normal pregnancy. In the second trimes­
ter, this usually represents a systolic de­
crease o f 5-10 mmHg and a diastolic de­
crease of 10-20 mmHg. These changes 
gradually return toward, or perhaps slightly 
above, the prepregnant levels by the end of 
pregnancy. Thus, what is normal pressure 
in the nonpregnant state may be considered 
abnormal in the middle portion of preg­
nancy. For example, a blood pressure of 
140/90 mmHg would be a considered bor­
derline level in the nonpregnant state. 
However, it should be considered distinctly 
abnormal at 20 weeks’ gestation, reflecting 
either a prepregnant pressure o f approxi­
mately 145-150/100-110 mmHg or a fail­
ure of the maternal vascular volume to ex­
pand. In either case, such a pregnancy is at 
increased risk for superimposed pre­
eclampsia, abruption, stillbirth, a small-for- 
gestational age fetus, and various neonatal 
complications.
Many o f the normal cardiovascular 
changes in pregnancy could be miscon­
strued as representing primary cardiovas­
cular disease. Cruikshank and Hays5 note 
that a number of physiologic changes of 
normal pregnancy might be misdiagnosed 
as heart disease (Table 3).
TABLE 3. Signs and Symptoms o f Normal 
Pregnancy That May Mimic 
Heart Disease
Symptoms 





Point o f  maximal impulse displaced laterally 
Auscultation 
Increased splitting o f first and second heart sounds 
Third heart sound (S3 gallop)Systolic ejection murmur along left sternal border 
Chest radiography 
Straightening ofleft heart border 
Heart position more horizontal 
Increased cardiothoracic ratio 
Increased pulmonary vascular markings 
Electrocardiogram 
Left axis deviation (without hypertrophy) 
Nonspecific ST-T wave changes
From Cruikshank DP, Hays PM.5 By permission.
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Labor and delivery, as well as the im­
mediate puerperium, are periods o f in­
creased cardiovascular stress. During labor, 
cardiac output may increase further by as 
much as 40%. Although some of this is un­
doubtedly the result of response to pain,6 
some is also due to the cardiovascular ef­
fects o f labor contractions. Each contraction 
squeezes 300-500 ml of blood out of the 
uterus and into the maternal vasculature. 
This leads to increased venous return and 
subsequent increased cardiac output. The 
immediate puerperium also is associated 
with changes in cardiac output as a result 
of immediate “auto transfusion” o f500-800 
ml of volume previously contained within 
the vasculature of the term uterus. There is 
also a substantial mobilization o f intracel­
lular fluid in the first 48 hours postpartum. 
Both result in a 10-20% increase in cardiac 
output, reflex bradycardia, and increased 
stroke volume.
Histologic changes in the peripheral vas­
culature also occur during pregnancy. These 
include hyperplasia of the arterial and ve­
nous intima and changes in the organization 
and content of the arterial media. These 
conditions may predispose the pregnant 
woman to the formation or rupture of ar­
terial aneurysms.
Because o f the multiple changes in the 
cardiovascular system during pregnancy, 
the hemodynamic status of the pregnant 
woman is often confusing. Therefore, 
acutely ill, pregnant surgical patients may 
benefit more often from invasive hemody­
namic monitoring to facilitate appropriate 
fluid resuscitation and care.
Respiratory System
Maternal respiratory adaptations during 
pregnancy can be understood best if one 
considers that the pregnant woman must 
get oxygen in and carbon dioxide out for 
two individuals. Fetal oxygen requirements 
increase exponentially during pregnancy. 
This is reflected clinically as a progressive
increase in minute volume during preg­
nancy. Although the diaphragm is elevated 
during pregnancy, actual diaphragmatic 
excursion is not impeded. This physiologic 
“hyperventilation” requires greater use of 
the accessory breathing muscles. The pro­
gressive circumferential expansion o f the 
chest cage during pregnancy, averaging 
5-7 cm, frequently results in disruption of 
chest wall proprioceptors. The combined 
reduction in maternal Pec* a°d  increase in 
tidal volume accounts for the sensation of 
dyspnea and breathlessness reported by two 
thirds of pregnant women.
Changes in pulmonary-function testing 
associated with pregnancy also reflect the 
need for increased maternal gas exchange. 
The progressive increase in tidal volume 
and minute respiration reach 30-40% by 
term. Because vital capacity and respiratory 
rate remain unchanged, the increase in tidal 
volume occurs in association with a de­
crease in expiratory reserve volume.
Neither forced vital capacity nor forced 
expiratory volume are altered by pregnancy, 
consistent with the observation that large 
airway function is unaltered by pregnancy.7 
Likewise, there is no evidence of impaired 
small airway function in pregnancy.8
Analysis of arterial blood gases during 
pregnancy reflects this physiologic hyper­
ventilation. Maternal Pec* is decreased, and 
maternal pH is increased. Because oxygen 
consumption increases less (15-20%) dur­
ing pregnancy than does minute ventilation, 
a modest increase in maternal arterial P02 
levels occurs. These changes in maternal 
Pee* and Pc* are important because they 
enhance the exchange gradients between 
other and fetus for carbon dioxide and 
oxygen. The partially compensated respi­
ratory alkalosis is apparent within the first 
few months o f pregnancy. Women with sig­
nificant pulmonary disease, especially o f an 
obstructive nature, are affected adversely by 
the physiologic changes o f pregnancy. By 
far, the most common respiratory disease 
seen in association with pregnancy is
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asthma. Because of its intermittent nature, 
the predictability o f its course during preg­
nancy is often difficult.
Ophthalmic Changes
Many o f the ophthalmic changes in normal 
pregnancy are the result o f the modest in­
crease in extracellular fluid. Other physio­
logic changes that have ophthalmic impli­
cations include progressive increases in 
melanocyte-stimulating hormone and en­
largement o f the pituitary gland.
Progressive hyperpigmentation o f the 
eyelids is the result o f increased melanocyte- 
stimulating hormone. Pregnancy does not 
affect extraocular eye movements but is as­
sociated with a modest increase in corneal 
edema. As a result, contact lenses may not 
fit as well during pregnancy. In addition, 
there appears to be a decrease in comeal 
sensitivity during the third trimester. There 
is also a modest increase in extracellular 
fluid in the lens during pregnancy, resulting 
in a tendency toward myopia.
Intraocular pressure tends to decrease 
during the second half of pregnancy, sug­
gesting that glaucoma and its sequelae 
might be less common in pregnant women. 
Because there are no normal pregnancy-as­
sociated changes in the retina, any observed 
retinal changes must be explored further. 
The pituitary gland increases in size during 
pregnancy, and a modest bitemporal hemi­
anopsia can occur in some women.
There are no other normal pregnancy- 
associated changes in the optic nerve, 
chiasm, or retrochiasmatic structures. Spe­
cifically, normal pregnancy is not associated 
with increased intracranial pressure or 
papilledema.
Otorhinolaryngologic Changes
Most otorhinolaryngologic changes asso­
ciated with pregnancy are the result o f pro­
gesterone-mediated mucosal hyperemia. 
This hyperemia is most apparent in the
oropharynx. Hyperemia o f the nasal mu­
cosa increases the frequency and severity of 
epistaxies and may cause symptomatic na­
sal congestion. In pronounced cases, this 
occurrence may be misinterpreted as a 
chronic upper respiratory infection, and 
only modest improvement is achieved with 
medications. However, these symptoms 
dramatically resolve 2-3 days postpartum, 
in conjunction with the postpartum de­
crease in mucosal hyperemia.
In addition, pregnant women with 
preexisting periodontal disease can antici­
pate exacerbation. There are changes in the 
oral cavity microbial flora that approximate 
those seen in the reproductive tract.
Mucosal edema in the oropharynx has 
significant anesthetic implications. As mu­
cosal edema increases, especially in the 
third trimester or with preeclampsia, intu­
bation and general anesthesia become more 
difficult. The visibility necessary for intu­
bation may be compromised, requiring fi­
beroptic procedures, awake intubations, or, 
possibly, a significant delay o f surgical pro­
cedures. In extreme emergencies, the sur­
geon must be prepared always to perform 
a tracheostomy to restore the maternal air­
way.
Mucosal hyperemia may predispose a 
woman to functional occlusion o f the eu­
stachian canal. This occlusion frequently 
becomes symptomatic when pregnant 
women experience sudden changes in alti­
tude (e.g., during travel by airplane). The 
modest increase in extracellular fluid in the 
semicircular canals also may explain in part 
why pregnant women are likely to experi­
ence transient dizziness with sudden 
changes in position. Pregnant women are 
also relatively more likely to experience 
symptomatic accumulation o f cerumen in 
the external auditory canal.
Endocrine System
The endocrine system undergoes profound 
alterations during pregnancy. Many of these
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changes reflect progressive estrogen-me­
diated increases in hormone binding pro­
teins.
Although hypothalamic function appears 
unaltered during pregnancy, there is a pro­
gressive increase in pituitary size and blood 
flow during pregnancy- This increase in pi­
tuitary blood flow is responsible partly for 
the increased susceptibility o f the gland to 
ischemic necrosis during pregnancy and the 
immediate puerperium (Sheehan’s syn­
drome).
Prolactin levels progressively increase 
from early in pregnancy. This change has 
obvious clinical importance, because it ne­
gates the usefulness of this blood test for 
diagnosing or following prolactinomas.
Pregnancy is associated with a progres­
sive increase in thyroid-binding globulin. 
This increase results in a characteristic al­
teration in thyroid-function tests with an 
increase in total T4, a decrease in Tr resin 
uptake, and an unchanged thyroid function 
index (reported by most laboratories as a 
T7 or free-thyroid index) (Table 4). Al­
though recent laboratory analysis suggests 
that there may be a modest increase in free 
T4 during pregnancy, this increase in free 
T4 is controversial and is not of major clin­
ical significance.
Pregnancy is also associated with a pro­
gressive increase in corticosteroid-binding 
globulin, resulting in an elevated plasma 
cortisol concentration. By the end o f preg­
nancy, this increase in total cortisol may be 
as much as a threefold. Because the pro­
portion of bound and free cortisol does not 
change during pregnancy, there is a relative 
increase in free cortisol during pregnancy. 
Although these increased levels may overlap 
with levels seen in Cushing’s syndrome, 
diurnal variability is preserved and serves 
as a potentially valuable clinical discrimi­
nator.
There is no consistent increase in total 
weight o f the normal adrenal gland, al­
though there is a relative increase in the 
zona fasciculata. The zona fasciculata is re-
TABLE 4. Pregnancy-Associated Changes in 
Thyroid Function Tests
Nonpregnant Pregnant
TBG (ng/dl) 19-30 40-60
T4 (ng/dl) 5-10 8-16
T j (ng/dl) 65-14 140-180
RT3U (%) 30-40 <30FTI (“T7) 1.5-4.0 1.5-4.0
sponsible for glucocorticoid production. Its 
increase is compatible with laboratory ob­
servations that the increase in circulating 
glucocorticoids is the result not only of in­
creased corticosteroid-binding globulin and 
decreased clearance, but of increased pro­
duction as well. Those changes return to, 
or below, prepregnant values within the first 
2 weeks postpartum and may explain in part 
the pregnancy-associated improvement of 
some autoimmune diseases (notably rheu­
matoid arthritis) as well as the puerperal 
exacerbation of others (e.g., systemic lupus 
erythematosus).
Other alterations occur in maternal cor­
ticosteroid concentrations that are not the 
exclusive result o f altered maternal physi­
ology. Pregnancy is associated with pro­
gressive increases in deoxycorticosterone, 
but this reflects increased production by the 
fetoplacental unit. Maternal levels are not 
affected either by adrenocorticotrophic 
hormone administration or by dexameth- 
asone suppression.
The adrenal medulla also is affected by 
pregnancy. Normal pregnancy is associated 
with a substantial and progressive increase 
in aldosterone levels. This increase pro­
motes sodium reabsorption in the renal tu­
bules. Although estrogens and deoxycorti­
costerone also function in this way, the ma­
jo r increase in circulating aldosterone levels 
is the predominant mechanism by which 
the net sodium requirements of pregnancy 
(900-1,000 mEq Na+ in the fetus, placenta, 
and maternal intra- and extra-vascular 
space) are m et These changes are necessary 
because there otherwise exists during preg­
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nancy the possibility o f a significant natri- 
uresis as a  result o f the increased glomerular 
filtration rate and increasing progesterone 
concentrations.
Normal pregnancy is characterized by 
accelerated starvation in the fasting state. 
Fasting blood sugars are normally 10-15 
mg% below those seen in the nonpregnant 
state. This is the result primarily o f the con­
tinuous transplacental metabolic drain of 
glucose to the fetus and is not due to a per­
sistent hyperinsulinemia. In fact, the unfed 
state generally is thought to be associated 
with hypoinsulinemia. During pregnancy, 
starvation predisposes the woman to ketosis 
because o f rapid transplacental shunting of 
glucose and a decrease in serum buffering 
capacity. On the other hand, the fed state 
during pregnancy is characterized by hy­
perglycemia and hyperinsulinemia. This 
apparently paradoxical situation is ex­
plained by the progressive increase o f hor­
mones that are functional insulin antago­
nists. These include estrogens, progestins, 
adrenal corticosteroids, and human pla­
cental lactogen. These result in a 60-80% 
increase in insulin resistance during preg­
nancy.
While most pregnant women respond to 
these changes by producing sufficient extra 
insulin, 44-6% o f pregnant women will be 
unable to increase their insulin production 
adequately and will develop gestational di­
abetes. Women particularly prone to this 
complication include those who have a 
family history o f type II diabetes or are 
obese, and those who have a past obstetric 
history of delivering large or anomalous 
babies or having unexplained stillbirths.
Together, the fetus and placenta produce 
the majority of biologically active hormones 
in the maternal compartment. Human cho­
rionic gonadotropin, synthesized by the 
syncytiotrophoblast in the placenta, is a lu- 
teotrophic agent that maintains the corpus 
luteum during early pregnancy. It also en­
hances steroidogenesis in the placenta and 
the fetal adrenal gland and also is of value
as a tumor marker for various trophoblastic 
and nontrophoblastic malignancies. Certain 
systemic diseases (e.g., urinary tract infec­
tion, proteinuria, hematuria, and systemic 
lupus erythematosus) can cause false-posi­
tive human chorionic gonadotropin assays, 
as can certain drugs (i.e., phenothiazines, 
barbiturates, methadone, and penicillin).
As previously mentioned, progesterone 
causes numerous physiologic effects in 
pregnancy. In the first few weeks after con­
ception, it is produced primarily by the cor­
pus luteum. After the first 8-10 weeks, the 
majority of progesterone is produced by the 
fetoplacental unit.
Human placental lactogen production by 
the syncytiotrophoblast is directly propor­
tional to the functional placental size. It is 
secreted primarily into the maternal com­
partment, where it facilitates adequate nu­
trient delivery to the fetus (lipolysis, ma­
ternal insulin antagonism).9
Orthopedic Changes
Pregnancy is characterized by progressive 
ligamentous laxity, especially of the weight­
bearing joints. This is caused by the effects 
of progesterone and relaxin. Mobility o f the 
pelvic synchondroses and the pubic sym­
physis can be demonstrated radiographi- 
cally and undoubtedly facilitates normal 
vaginal delivery. Unfortunately, these 
changes also may lead to pelvic discomfort 
late in pregnancy. In an attempt to maintain 
the center of balance over the legs, the preg­
nant woman experiences progressive out­
ward rotation o f the femurs as well as lum­
bar lordosis with thoracic kyphosis and cer­
vical lordosis. Consequently, there is a 
greatly increased incidence o f low back dis­
comfort and exacerbation o f preexisting 
lumbosacral disc disease. These changes 
predispose the pregnant woman to an un­
steady gait, and pregnancy is a period of 
increased risk for falls and other trauma. 
However, pregnancy also is associated with 
increased rates of domestic violence, and
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this possibility always should be considered 
in the differential diagnosis o f orthopedic 
and soft tissue injury.
The increase in extracellular fluid accu­
mulation during pregnancy predisposes the 
pregnant woman to entrapment syndromes, 
particularly carpal tunnel syndrome. Total 
maternal serum calcium concentrations 
gradually decrease during pregnancy, pri­
marily because o f the progressive decrease 
in serum albumin that occurs during preg­
nancy.10 The ionized calcium concentration 
remains unchanged during gestation, in 
spite o f several changes that might be ex­
pected to cause a decrease. These changes 
include transplacental calcium transfer, in­
creased extracellular fluid volume, and the 
increased glomerular filtration rate. The 
ionized calcium concentration is main­
tained at a  normal nonpregnant level as a 
result o f a progressive increase in the para­
thyroid hormone concentration, which 
reaches over 100% above nonpregnant val­
ues by term. In spite o f this increase in 
parathyroid hormone concentration, no 
significant calcium is lost from bone, per­
haps because o f a secondary increase in cal­
citonin concentration during pregnancy.
Neurologic Changes
There is no evidence that central nervous 
system blood flow is altered by pregnancy, 
although pregnancy does seem to increase 
the frequency o f cerebrovascular disease. 
The majority of physiologic changes in the 
nervous system reflect peripheral nerve en­
trapment syndromes due to increased ex­
tracellular fluid retention or hormonally 
mediated ligamentous relaxation.
Muscle cramps are distinctly more com­
mon during pregnancy. It is estimated that 
as many as 30% of pregnant women expe­
rience painful muscle cramps,1 ,J2 almost 
always involving the leg muscles and fre­
quently occurring at night. The cause of leg 
cramps during pregnancy remains un­
known. It clearly is not related to precon-
ceptual conditioning, although vigorous 
exercise may aggravate the tendency. Like­
wise, women who experience leg cramps 
before conception may find them to occur 
more frequently and be more severe during 
pregnancy, particularly if other predispos­
ing factors, such as salt depletion, dehydra­
tion, uremia, or hypothyroidism also are 
present. Likewise, certain rare medical 
complications may be associated with mus­
cle cramps plus generalized weakness in­
cluding extrapyramidal or pyramidal dis 
orders, amyotrophic lateral sclerosis, 
tetanus, or myophosphorylase deficiency 
(McArdle’s Disease).
Renal System
The major renal adaptations to pregnancy 
result from pregnant woman’s efforts to 
clear not only her own fixed metabolic 
wastes but those o f the fetus as well. This 
is accomplished via increased renal blood 
flow and glomerular filtration. Increased 
renal blood flow is associated with an in­
crease in renal vascular and interstitial vol­
ume, resulting in increased renal size during 
pregnancy. Whether measured by renal 
plasma flow or glomerular filtration rate, 
renal blood flow increases within a few 
weeks after conception. This increase is as­
sociated with many alterations in normal 
laboratory values. There is an increase in 
creatinine clearance during pregnancy to an 
average o f 110-160 ml/min, as well as a de­
crease in serum creatinine concentration 
(normal value in pregnancy, <  0.9 mg%), 
serum blood urea nitrogen concentration 
(normal value in pregnancy, < 1 5  mg%), 
and serum uric acid concentration (normal 
value in pregnancy, <  6 mg%). These 
changes are prominent by the end o f the 
first trimester and are outlined in Table 5.
It is important to remember these 
changes, because a patient with moderate 
renal disease may have falsely normal-ap­
pearing laboratory parameters beyond the 
end o f the first trimester. There is no sig-
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TABLE 5. Changes during Pregnancy o f Renal Function Parameters
Relative Change Nonpregnant Late Pregnancy
Renal plasma flow (ml/min)  ^
Glomerular filtration rate (ml/min) 
Creatinine clearance 
Blood urea (BUN) (mg%) 
Creatinine (mg%)
Uric acid (mg%)
Plasma osmolality (mOsm/kg 
H20 )Aldosterone (ng/I)
Plasma renin activity 
Proteinuria (mg/24 hr)
nificant increase in urinary protein excre­
tion during pregnancy, although specimen 
contamination with vaginal secretions nor­
mally may increase total urinary protein 
concentration to as much as 300 mg per 24 
hours.Pregnancy is associated with progressive 
ureteral and renal pelvic dilation, resulting 
in a doubling of collecting-system volume 
due to the effects of progesterone on ureteral 
smooth muscle as well as compression by 
the enlarging uterus and infundibulopelvic 
ligaments. These changes, more prominent 
on the maternal right side than on the left, 
result in characteristic changes on intrave­
nous pyelography, including ureteral dila­
tion (greater on the right than the left), 
blunting of the renal calyces, and an in­
crease in renal size. As a result of these 
changes, pregnant women with bacteriuria 
are at an increased risk for developing 
symptomatic upper urinary tract infection. 
Pregnancy per se does not increase the risk 
o f asymptomatic bacteriuria.
Plasma osmolality begins to decrease 
within the first month after conception, and 
by the end o f the first trimester decreases 
by 10 mOsm/kg. This decrease is due pri­
marily to a decrease in the serum sodium 
concentration. In spite of this change, so­
dium metabolism is altered during preg­
nancy to allow the accumulation o f ap­
proximately 1,000 mEq o f sodium. Al­
though the increases in glomerular filtration
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rate and serum progesterone might be ex­
pected to cause an increase in urinary so­
dium excretion, these changes are more 
than offset by increased renal tubular reab­
sorption. Renal tubular absorption is me­
diated by increased concentrations of al­
dosterone, desoxycorticosterone, and es­
trogen during pregnancy.
There are also significant changes in the 
renin-angiotensin system during preg­
nancy, and these, in turn, are responsible 
for the observed increase in aldosterone. 
Plasma renin activity is increased by ap­
proximately five times, as are concentra­
tions o f angiotensin and angiotensinogen. 
The normal pregnant woman has a sub­
stantially reduced sensitivity to these va­
sopressors, but their increase leads to the 
aforementioned increase in aldosterone 
production. Women who subsequently de­
velop preeclampsia show evidence of in­
creased sensitivity to these vasopressors 
many weeks before their disease becomes 
clinically evident. Recent evidence suggests 
that this altered sensitivity has a strong ge­
netic component.
Urinary glucose excretion is increased in 
most pregnant women, primarily because 
o f the increased glomerular filtration rate. 
As a result, as much as 25% of all pregnant 
women have glycosuria during pregnancy. 
Clinicians appropriately manage diabetes 
via blood glucose determinations, because 
these physiologic alterations make urine
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TABLE 6. Changes during Pregnancy in Serum Chemistries Reflecting Hepatic Function
Parameter Change Normal Nonpregnant Value Late Pregnancy Value
Total protein (g/dl) 1 6.5-7.5 5.7-6.5Albumin (g/di) 1 3.2-3.8 2.4-3.1Alkaline phosphatase (IU/1) t 30-115 100-210Aspartate transaminase (IU/1) - 0-31 Unchanged
Lactate dehydrogenase (IU/1) - 100-210 Unchanged
Total bilirubin (mg/dl) - 0.26-1.00 Unchanged
Prothrombin time (seconds) - 10-13 Unchanged
Partial thromboplastin time (seconds) - 22-33 Unchanged
Bleeding time - <;8 Unchanged
Cholesterol (mg/dl) t 120-190 190-330Triglycerides (mg/dl) t 76-92 205-247
glucose values unreliable. Likewise, there is 
a progressive urinary excretion of many, but 
not all, amino acids.13
Gastrointestinal System
Most physiologic alterations of the gas­
trointestinal tract during pregnancy are the 
result o f progesterone-mediated smooth 
muscle relaxation or mechanical displace­
ment o f the abdominal viscera by the en­
larging uterus. This displacement occurs in 
superior, lateral, and posterior directions.
Progesterone causes a decrease in the 
tone o f the functional gastroesophageal 
sphincter, resulting clinically in increased 
heartburn. Likewise, there is an increase in 
small bowel transit time, allowing more 
complete absorption o f nutrients. The in­
creased transit time in the colon promotes 
more complete water absorption and con­
stipation.
Although appendicitis is no more com­
mon in pregnant women than it is in non­
pregnant women, it is more serious in preg­
nancy for the following reasons: the appen­
dix is displaced upward and outward from 
McBumey’s point (and therefore often 
misdiagnosed as cholecystitis) late in preg­
nancy; there is a general reticence among 
physicians to perform exploratory laparot­
omies on pregnant women; and, if  the ap­
pendix ruptures, the omentum is less ca­
pable o f preventing a generalized perito­
nitis.14
Cholecystitis may be another source of 
acute abdominal pain in a  pregnant woman. 
While 95% of nonpregnant women have 
gallstone cholecystitis, gallstones are found 
in only 50-90% of pregnant woman with 
symptomatic cholecystitis. Murphy’s sign is 
positive in only about 5% o f pregnant 
women with cholecystitis, and laboratory 
tests o f liver function are less likely to be 
abnormal during pregnancy. Although con­
servative management is the initial treat­
ment of choice, delaying appropriate sur­
gical therapy is not warranted. Both open 
and laparoscopic techniques have been de­
scribed during pregnancy with low compli­
cation rates.15-17
There is no change in hepatic blood flow 
during pregnancy, but several serum chem­
istries reflective of liver dysfunction may 
be altered by normal pregnancy (Table 6). 
There is a decrease in total protein and al­
bumin concentrations. Serum alkaline 
phosphatase concentrations progressively 
increase during pregnancy and reflect pla­
cental production (heat-stable) rather than 
obstructive liver disease or bone disease. 
Serum cholesterol levels increase through­
out pregnancy and are approximately dou­
ble the nonpregnant levels by term.
There are no changes normally asso­
ciated with pregnancy in the serum levels 
of transaminases, lactate dehydrogenase, 
and bilirubin. Alternative explanations for 
abnormalities in these values always must 
be sought.
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Although concentrations of fibrinogen 
and factors VII-X increase during preg­
nancy, concentrations o f factors V and XII, 
as well as factor II (prothrombin), remain 
unchanged, and concentrations o f factors 
XI and XIII decrease. There are no changes 
in the standard coagulation function tests, 
and the bleeding time is normal during 
pregnancy. Nonetheless, pregnancy gener­
ally is considered a hypercoagulable state. 
Although pregnancy is associated with a 
1.5-2.0-fold increase in thromboembolic 
disorders, the first few weeks o f the puer- 
perium is actually the period o f greatest risk, 
with relative risks generally noted to be be­
tween four- and sixfold greater than in the 
nonpregnant state. This certainly demon­
strates the importance o f small vessel in­
jury and stasis for the development of 
thromboembolic disorders.
Acute abdominal pain, regardless of 
cause, is a great source of confusion for the 
physician and surgeon. Almost 50% of pre­
operative diagnoses in pregnant women 
with acute abdominal pain are incorrect19; 
therefore, a firm preoperative diagnosis is 
not always essential. Although perinatal 
outcome depends on the severity o f the un­
derlying disease process, delay in the di­
agnosis and therapy is the major cause of 
excessive maternal and fetal morbidity and 
mortality.1’1819 By far, the most common 
complication reported from surgical dis­
eases and procedures is preterm labor.
In addition to appendicitis and chole­
cystitis, other potential surgical diseases in 
pregnancy include gallstone pancreatitis, 
adnexal masses or torsion, and acute 
trauma.2**22
Hematologic Changes
Not only does maternal blood volume ex­
pand by 30-50% during normal pregnancy, 
but circulating red blood cell mass also in­
creases by 20-30%. The net result is that 
pregnant women have an apparent decrease 
in their hematocrit, even though their total
oxygen carrying capacity is increased. This 
makes teleologic sense: If a pregnant woman 
must pump 30-50% more blood through 
her vascular system 30-50% faster than she 
does in the nonpregnant state, it would be 
easier to do if that blood were less viscous. 
Certainly, the once-held opinion that preg­
nancy represented a “physiologic anemia” 
should be discarded. Normal pregnancy is 
associated with a 10-20% relative decrease 
in hematocrit, which is maximal at about
34 weeks’ gestation. In fact, hematocrit lev­
els that do not decrease are associated with 
failure of maternal volume expansion. This, 
in turn, places the pregnancy at risk for 
complications, including small-for-gesta- 
tional age fetus, premature labor, and still­
birth. The increase in maternal blood vol­
ume also protects the mother from hem­
orrhage at the time of delivery, dissipates 
fetal metabolic heat, and provides adequate 
renal and placental perfusion.
Although iron and folate supplementa­
tion is appropriate to optimize maternal 
hematopoiesis, it need not be prescribed in 
quantities sufficient to maintain maternal 
hematocrits at nonpregnant levels. The 
purpose of iron supplementation during 
pregnancy is to prevent iron deficiency in 
the mother, not to maintain the maternal 
hematocrit or supplement the fetus. Iron is 
transported actively across the placenta, 
even with clinical and laboratory evidence 
of iron deficiency in the mother. In this re­
gard, red blood cell indices do not change 
during a normal pregnancy.
Peripheral white blood cell counts pro­
gressively increase during pregnancy. By the 
end of the first trimester, the average white 
blood cell count is between 9,000 cells/mm 
and 10,000 cells/mm,3 with a modest fur­
ther increase through the second and third 
trimesters. Labor and the immediate puer- 
perium may be associated with a substantial 
leukocytosis, to as high as 20,000-30,000 
cells/mm3 and do not necessarily reflect 
other underlying pathology. These increases 
are primarily in leukocytes. Although the
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number o f lymphocytes remains un­
changed, the number o f helper T3-cells de­
creases through the course of pregnancy. 
This suggests that the acquired immune de­
ficiency syndrome may be unmasked or ex­
acerbated by pregnancy, although there is 
no clinical evidence for this hypothesis.
Platelet counts decrease modestly during 
pregnancy, although the platelet count in a 
normal pregnancy should remain within the 
normal range for a nonpregnant woman. 
There is evidence to suggest that the average 
platelet lifespan is somewhat shorter during 
pregnancy. This is manifested by a modest 
increase in platelet size during pregnancy, 
reflecting the presence o f younger, and 
therefore larger, platelets in the peripheral 
circulation. Platelets also are likely to ag­
gregate in late pregnancy and the puerper- 
ium. This may explain in part the increased 
incidence o f cerebrovascular disease during 
this time.
The relative increase in circulating coag­
ulation factors during pregnancy is associated 
with an increased incidence of cerebrovas­
cular disease. This increase is particularly 
prominent in the first few weeks postpartum, 
especially if the pregnancy has been compli­
cated by preeclampsia, chronic hypertension, 
or a  significant hypotensive episode.
Dermatologic Changes
Pregnancy is associated with progressive, in­
creased pigmentation in areas of high mela­
nocyte concentration, particularly the eyelids, 
areola, linea nigra, and external genitalia. This 
is the combined effect o f progressive increases 
o f melanocyte-stimulating hormone, estro­
gen, and progesterone. Estrogen and proges­
terone also seem to be responsible for the oc­
casional development of chloasma in preg­
nant women. This frequently is referred to as 
the “mask of pregnancy” and represents a 
photosensitive hyperpigmentation. It also 
may be seen in women taking oral contra­
ceptives. Although this condition may fade 
after delivery, little can be done to treat it,
and it is best prevented with sunscreen prep­
arations.
Palmar erythema and/or spider nevi are 
seen commonly in pregnant women, with 
two thirds o f women having one or both. 
The spider nevi are most common over the 
area o f superior vena cava distribution. 
These changes reflect the progressive in­
crease in circulating estrogen levels during 
pregnancy and do not represent hepatocel­
lular dysfunction.
Pregnant women frequently report that 
their hair is coarser and/or straighter than 
normal. Alopecia is seen occasionally in as­
sociation with pregnancy but is very com­
mon at 2-4  months postpartum. This is a 
transient phenomenon and should be ex­
pected to be resolved by 6-12 months post­
partum.
Pregnancy also may be associated with a 
more masculine hair distribution pattern. 
This reflects a modest but progressive in­
crease in circulating androgen levels during 
pregnancy, and patients can be reassured 
that these changes will be resolved post­
partum. Significant masculinization is not 
normal and requires further investigation.
Women are more diaphoretic during 
pregnancy. In a large part, this represents 
their need to dissipate not only their own 
metabolic heat but that of the fetus as well.
Stretch marks, or striae, are common in 
pregnancy, being somewhat more common 
in women who are tall, obese, or blonde. 
They are seen most commonly on the 
breasts, lower abdomen, buttocks, and an­
terior thigh. Their cause remains unclear 
but is probably a combination of collagen- 
fibril weakening and mechanical disruption 
by expanding underlying tissue in geneti­
cally predisposed individuals. There as yet 
is no effective prophylaxis.
Psychiatric/PsychologicChanges
Most pregnant women have some degree of 
anxiety or apprehension about their preg­
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nancy. This often is evident as the fear of 
delivering an abnormal infant, concern 
about injury or pain during labor and de­
livery, or ambivalence toward the preg­
nancy or parenthood. Appreciation that 
these apprehensions are common allows the 
health care provider to resolve them with 
explanations and/or counselling.
Pregnancy, labor and delivery, and par­
enthood are stressful events. Therefore, they 
might be expected to unmask latent psy­
chiatric disease or psychologic dysfunction. 
This issue is confused further by the pro­
found hormonal changes that occur during 
pregnancy and the puerperium, which may 
have psychologic implications.
Postpartum depression is a very common 
occurrence, with over half o f all puerperal 
women having some degree o f transient 
depression. This occurs most commonly 
around 3-7 days postpartum. As long as it 
is short lived (a few days) and is not asso­
ciated with suicidal thoughts or attempts or 
delusional ideation, patients may be reas­
sured. If any of the above psychiatric signs 
are seen, however, prompt psychiatric con­
sultation is mandatory.
Conclusion
Almost every system is affected in some 
manner by pregnancy and the postpartum 
period. This may have profound effects on 
the course of surgical diseases in these 
women, the choice o f diagnosis, and the 
treatment protocols used to treat them. It 
therefore is important for physicians deal­
ing with women in the reproductive age 
group, especially during pregnancy, to ob­
tain a working knowledge of the physiologic 
state o f pregnancy and the puerperium. It 
also is important to remember that the most 
severe complications from surgical diseases 
in pregnant women result fr^m delayed di­
agnosis and subsequently delayed treat­
ment. Some of these complications can be 
avoided, given adequate understanding of 
the changes occurring during pregnancy and
the puerperium along with the knowledge 
o f the surgical disease processes.
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